Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Patent Issued for Crispr-Edited Viruses in Microbiome

Crispr-Cas9

A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome

Start-Up Licenses Gene-Edited Drug Discovery Tech.

African clawed frog

A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech.

Venture to Build Cell, Gene Therapy Businesses

Gene therapy graphic

A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses

Cannabinoid Synthesis Process Licensed to Spin-Off Company

DNA illustration

A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process. . . . → Read More: Cannabinoid Synthesis Process Licensed to Spin-Off Company

Univ. Labs Ink Licensing Deals for Covid-19 Tests

Home testing station

Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests

Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M

DNA puzzle

A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments. . . . → Read More: Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M

Women’s Health Companies Partner on New Contraceptive

Women silhouettes

Two companies working in women’s reproductive health are developing a new non-hormonal contraceptive that works in cervical mucous membranes. . . . → Read More: Women’s Health Companies Partner on New Contraceptive

Biotechs Explore Gut-Brain Axis for Mental Health

Microbiome graphic

Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders. . . . → Read More: Biotechs Explore Gut-Brain Axis for Mental Health

CEPI Funds New Broad Coronavirus Vaccine

Exosome illustration

An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine

Biotech in $1.5B Gene-Editing Tech License Deal

Sickle cell illustration

A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease. . . . → Read More: Biotech in $1.5B Gene-Editing Tech License Deal